Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs

Author:

Porreca Angelo,Del Giudice Francesco,Giampaoli Marco,D’Agostino Daniele,Romagnoli Daniele,Corsi Paolo,Del Rosso Alessandro,Maggi Martina,Chung Benjamin I.,Ferro Matteo,de Cobelli Ottavio,Lucarelli Giuseppe,Schiavina Riccardo,De Berardinis Ettore,Sciarra Alessandro,Busetto Gian Maria

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. Cancer statistics 2012;Siegel;CA Cancer J Clin,2012

2. Adverse features and competing risk mortality in patients with high-risk prostate cancer;Vagnoni;Clin Genitourin Cancer,2017

3. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate;Dickinson;Eur Urol,2011

4. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations;Panebianco;Anticancer Res,2011

5. State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer;Vagnoni;Arch Esp Urol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3